Serum aldosterone and the incidence of hypertension in nonhypertensive persons.
about
Intracellular Molecular Differences in Aldosterone- Compared to Cortisol-Secreting Adrenal Cortical AdenomasNew Evidence Supporting the Use of Mineralocorticoid Receptor Blockers in Drug-Resistant HypertensionWhole grains, type 2 diabetes, coronary heart disease, and hypertension: links to the aleurone preferred over indigestible fiberPharmacology of Aldosterone and the Effects of Mineralocorticoid Receptor Blockade on Cardiovascular SystemsThe role of the renin-angiotensin-aldosterone system in the pathobiology of pulmonary arterial hypertension (2013 Grover Conference series)Aldosterone synthase inhibition in humansKCNK3 Variants Are Associated With Hyperaldosteronism and Hypertension.Variations in the potassium channel genes KCNK3 and KCNK9 in relation to blood pressure and aldosterone production: an exploratory studyTASK-3 channel deletion in mice recapitulates low-renin essential hypertension.Rationale for combining a direct renin inhibitor with other renin- angiotensin system blockers. Focus on aliskiren and combinations.Adiponectin deficiency, diastolic dysfunction, and diastolic heart failure.Aldosterone dysregulation with aging predicts renal vascular function and cardiovascular risk.A systemic review of the relationship between aldosterone synthase - 344 C/T polymorphism and hypertension in Han.Racial differences in sensitivity of blood pressure to aldosteroneAldosterone receptor antagonists: effective but often forgotten.Aldosterone: role in the cardiometabolic syndrome and resistant hypertensionHigh-sodium intake aggravates myocardial injuries induced by aldosterone via oxidative stress in Sprague-Dawley rats.Rapid reversal of left ventricular hypertrophy and intracardiac volume overload in patients with resistant hypertension and hyperaldosteronism: a prospective clinical studyInteraction of aldosterone and extracellular volume in the pathogenesis of obesity-associated kidney disease: a narrative reviewPractical recommendations for treatment of hypertension in older patients.The past, present and future of renin-angiotensin aldosterone system inhibitionMineralocorticoid accelerates transition to heart failure with preserved ejection fraction via "nongenomic effects".Placental growth factor mediates aldosterone-dependent vascular injury in mice.Genetics of hypertension: from experimental animals to humans.Vascular endothelial function and hypertension: insights and directionsMultimarker approach for the prediction of heart failure incidence in the communityPathophysiology of resistant hypertension: the role of sympathetic nervous systemAldosteronism and resistant hypertension.Effects of aldosterone on insulin sensitivity and secretion.Circulating aldosterone and natriuretic peptides in the general community: relationship to cardiorenal and metabolic disease.Spironolactone and hydrochlorothiazide decrease vascular stiffness and blood pressure in geriatric hypertension.Human aldosterone synthase gene polymorphism promotes miRNA binding and regulates gene expressionThe renin-angiotensin-aldosterone system in adolescent offspring born prematurely to mothers with preeclampsia.Vitamin D and vascular disease: the current and future status of vitamin D therapy in hypertension and kidney diseaseRole of mineralocorticoid receptor antagonists in cardiovascular disease.Diagnostic value of I-131 NP-59 SPECT/CT scintigraphy in patients with subclinical or atypical features of primary aldosteronism.Association of aldosterone synthase polymorphism (CYP11B2 -344T>C) and genetic ancestry with atrial fibrillation and serum aldosterone in African Americans with heart failureLow Na, high K diet and the role of aldosterone in BK-mediated K excretion.Aldosterone: a forgotten mediator of the relationship between psychological stress and heart diseaseSodium reabsorption in the thick ascending limb in relation to blood pressure: a clinical perspective.
P2860
Q26742189-AEC5BCF3-D631-4D47-A835-91A04A4F2BB1Q26748793-1C83967F-15F4-4434-A13B-A7D6F80DD5FAQ26823966-06587373-1B98-46E5-9465-FEAF6CC42EF0Q27010641-32B0E9A3-A22F-4F90-8347-C828C77D6E63Q27013946-B3289DD9-D254-4522-92A4-49107CC99CCCQ27016157-9BDC5373-27C7-4969-91B8-D8D920552895Q30276621-9E53ED86-B894-45B8-9229-D1B16BFF938DQ30416599-D56E04A7-95D2-4872-AEE4-99AA20FB586EQ30419556-1504C35D-B391-4A52-AEDF-6F5BCE349ABCQ30452640-7E47346D-5F43-405C-A184-5C76B1DA7740Q33511929-CF9E8A7E-ECC1-429C-A61D-1248D2B3418BQ33590710-443F8106-0260-43AD-BAEA-C136C6905865Q33642037-8580FA2B-B86A-49B8-B4D4-7080DBD6894FQ33653549-C2616C85-4F08-41F9-89F0-AB3849BFA2C4Q33688485-B1A2D1DB-3129-41DB-9533-094E8840F929Q33736838-757070E3-9DC1-4996-BAA7-B3DE67A3297CQ33828715-2375CB33-64E7-491B-946C-E7431E414E5BQ33829892-0B663067-73B4-442E-AF08-A07682C7B701Q34018585-A461C29F-7C1B-4445-BD61-D1A4485DA08EQ34068754-48F47D60-8CFD-4EF9-80EE-ECA5D3B85495Q34094354-FCEB303C-F024-40C9-AFF5-8CF8A96025DCQ34121798-91BCCF0E-80EB-45F6-8362-921845888C19Q34245292-6A45B8F7-797A-4B60-9178-4AA56841A915Q34293919-B1E618A2-D2E2-4064-B202-BB84E1A4D197Q34316160-F80B1B3C-129F-4F19-BB5A-1D9397AAF335Q34357369-D20ED943-E002-4DED-AF45-2F319681BE63Q34557252-2EAA814A-4E89-4E5C-8848-CBEFFB8E617EQ34557307-56EC4439-745D-456C-BF9E-0C3814F19515Q34614820-14543C92-E26A-4AAB-85A2-03227D4AAFA3Q34714245-EA12B808-D020-4364-83BE-AF86E90ADC17Q34724494-C943B1D5-2B1B-4BE6-BDC4-842C3D70A3E7Q34726547-2F831651-CE81-4338-9CAB-F6DD6F087FE5Q34785051-E3DE1B3B-4D5D-4DFD-9521-CAE536C59B0EQ34797562-2D02DFBE-7049-49D6-AAF7-41C0194D7FF4Q34817129-8D94A0E5-7B41-48A2-A7CA-2D8308C7A322Q34895778-17E052E0-E603-4EB6-AD07-EAB0A96F05CFQ34923747-706930E7-F554-4EEA-BD5E-52ED9A6A3D04Q34994330-23F7E0C5-F695-4F16-A91A-EE29DAD11B63Q34997222-FAF474E3-02EF-4C49-B910-599F79FF17C7Q35094692-5490CF37-52EF-4687-A237-6AB20E4081FB
P2860
Serum aldosterone and the incidence of hypertension in nonhypertensive persons.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh
2004年學術文章
@zh-hant
name
Serum aldosterone and the incidence of hypertension in nonhypertensive persons.
@en
Serum aldosterone and the incidence of hypertension in nonhypertensive persons.
@nl
type
label
Serum aldosterone and the incidence of hypertension in nonhypertensive persons.
@en
Serum aldosterone and the incidence of hypertension in nonhypertensive persons.
@nl
prefLabel
Serum aldosterone and the incidence of hypertension in nonhypertensive persons.
@en
Serum aldosterone and the incidence of hypertension in nonhypertensive persons.
@nl
P2093
P50
P356
P1476
Serum aldosterone and the incidence of hypertension in nonhypertensive persons.
@en
P2093
Daniel Levy
Jane C Evans
Peter W F Wilson
P356
10.1056/NEJMOA033263
P407
P577
2004-07-01T00:00:00Z